Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $1.10 | Prev. Close $1.09 | Circuit Range N/A |
Day Range $1.09 - $1.11 | Year Range $1.03 - $12.06 | Volume 1,677 |
Average Traded $1.10 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $1.10 | $1.11 | +0.00% |
30-Jun-26 | $1.10 | $1.11 | +1.83% |
29-Jun-26 | $1.07 | $1.09 | +3.30% |
26-Jun-26 | $1.07 | $1.06 | +0.47% |
25-Jun-26 | $1.15 | $1.05 | -10.59% |
24-Jun-26 | $1.30 | $1.18 | -6.35% |
23-Jun-26 | $1.26 | $1.26 | +0.40% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?